3Roth JA.Centual visual field in diabetes.BR J ophthamol,1996,53:16-25.
4Pereir A, Suray jean-MD, Onkelinx C. Pharmacokinetics and safety of multiple oral doses of LY333531, a PKCβinhibitor in healthy elderly subjects. Diabetes, 1999, 361.
5Ko YD, Lee IK. Ishii H, et al. Prevention of glomeruler dysfunction in diabetic rats by treatment with d-α-tocophrcol. J Am Soc Nephrol, 1997, 8:426-435.
6Kunisaki M, Bursells E, Umeda F, et al. Vitamin E prevents diabeties-indueed abnomal retinal blook flow via the diacylglycerol protein kinese C pathway. Am J phsiol, 1995, 269:239.
7Bursell SE, Clermont AC, Aiello LP, eal. High-dose vitamine E supplementation normalizes retinal blood flow and creatinine clearance in patients with type Ⅰ diabetes. Diabetes Care, 1999, 8: 1245-1251.
8Wiedmann P. Growth factors in retinoal disease; proliferative viteoretinopathy, proliferative diabetic retinopathy, and retinal degeneration. Surv Ophthalmol, 1992, 36:373.
9Pfeiffer A, Schatz H. Diabetic microvascular complicatios and growth factors. Exp Clin Endocri, 1995, 103:7.
10GriggsJ, SkepperJN, Smith GA, Brindle KM, MetcalfeJC, Hesketh R. Inhibition of proliferative retinopathy by the anti-vascular gagent combretastatin-A4. Am J Pathol, 2002, 160 (3): 1097-1103.
